Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

Long-term Safety and Tolerability of AFFITOPE AD01

NCT00711139 ·Status: COMPLETED

Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease

NCT01117818 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)

NCT03668405 ·Status: TERMINATED ·Phase: PHASE1

A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

NCT05744401 ·Status: TERMINATED ·Phase: PHASE2

Safety and Tolerability of AFFITOPE AD03

NCT01309763 ·Status: COMPLETED ·Phase: PHASE1

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

NCT00633841 ·Status: COMPLETED ·Phase: PHASE1

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

NCT00495417 ·Status: COMPLETED ·Phase: PHASE1

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

NCT03819699 ·Status: TERMINATED ·Phase: PHASE1

Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease

NCT02388152 ·Status: TERMINATED ·Phase: PHASE1

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

NCT01676935 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)

NCT04374253 ·Status: TERMINATED ·Phase: PHASE3

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

NCT01369225 ·Status: COMPLETED ·Phase: PHASE1

An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US

NCT05097131 ·Status: TERMINATED

TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

NCT00203359 ·Status: COMPLETED ·Phase: PHASE1

A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease

NCT03112096 ·Status: COMPLETED ·Phase: PHASE1

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

NCT02245568 ·Status: TERMINATED ·Phase: PHASE3

Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial

NCT01417130 ·Status: UNKNOWN

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

NCT05476783 ·Status: TERMINATED ·Phase: PHASE2

Retrieval of Patient Information After Discontinuation

NCT01658722 ·Status: TERMINATED

Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

NCT01690195 ·Status: TERMINATED ·Phase: PHASE2

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

NCT01327859 ·Status: COMPLETED ·Phase: PHASE3

Comparative Research of Alzheimer's Disease Drugs

NCT01362686 ·Status: TERMINATED ·Phase: NA

Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

NCT01626391 ·Status: TERMINATED ·Phase: PHASE2

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

NCT04886063 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease

NCT05032482 ·Status: WITHDRAWN ·Phase: NA